DMD and cancer: Samples from patients with stage I cancer had significantly higher levels of DMD gene expression compared to those with stage II (LogFC = 0.72, p < 0.001), stage III (LogFC = 0.50, p < 0.001), and stage IV cancer (LogFC = 0.69, p < 0.001) (Figure 5A).